These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease. Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577 [TBL] [Abstract][Full Text] [Related]
6. Glucocerebrosidase gene therapy prevents α-synucleinopathy of midbrain dopamine neurons. Rocha EM; Smith GA; Park E; Cao H; Brown E; Hayes MA; Beagan J; McLean JR; Izen SC; Perez-Torres E; Hallett PJ; Isacson O Neurobiol Dis; 2015 Oct; 82():495-503. PubMed ID: 26392287 [TBL] [Abstract][Full Text] [Related]
7. Expression of mutant TDP-43 induces neuronal dysfunction in transgenic mice. Xu YF; Zhang YJ; Lin WL; Cao X; Stetler C; Dickson DW; Lewis J; Petrucelli L Mol Neurodegener; 2011 Oct; 6():73. PubMed ID: 22029574 [TBL] [Abstract][Full Text] [Related]
8. Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies. Higashi S; Iseki E; Yamamoto R; Minegishi M; Hino H; Fujisawa K; Togo T; Katsuse O; Uchikado H; Furukawa Y; Kosaka K; Arai H Brain Res; 2007 Dec; 1184():284-94. PubMed ID: 17963732 [TBL] [Abstract][Full Text] [Related]
9. Motor-Coordinative and Cognitive Dysfunction Caused by Mutant TDP-43 Could Be Reversed by Inhibiting Its Mitochondrial Localization. Wang W; Arakawa H; Wang L; Okolo O; Siedlak SL; Jiang Y; Gao J; Xie F; Petersen RB; Wang X Mol Ther; 2017 Jan; 25(1):127-139. PubMed ID: 28129109 [TBL] [Abstract][Full Text] [Related]
10. Caspase-cleaved transactivation response DNA-binding protein 43 in Parkinson's disease and dementia with Lewy bodies. Kokoulina P; Rohn TT Neurodegener Dis; 2010; 7(4):243-50. PubMed ID: 20551689 [TBL] [Abstract][Full Text] [Related]
11. Suppression of autophagy in the brain of transgenic mice with overexpression of А53Т-mutant α-synuclein as an early event at synucleinopathy progression. Pupyshev AB; Korolenko TA; Akopyan AA; Amstislavskaya TG; Tikhonova MA Neurosci Lett; 2018 Apr; 672():140-144. PubMed ID: 29203207 [TBL] [Abstract][Full Text] [Related]
12. Redistribution of DAT/α-synuclein complexes visualized by "in situ" proximity ligation assay in transgenic mice modelling early Parkinson's disease. Bellucci A; Navarria L; Falarti E; Zaltieri M; Bono F; Collo G; Spillantini MG; Missale C; Spano P PLoS One; 2011; 6(12):e27959. PubMed ID: 22163275 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease. Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678 [TBL] [Abstract][Full Text] [Related]
15. Selective loss of nigral dopamine neurons induced by overexpression of truncated human alpha-synuclein in mice. Wakamatsu M; Ishii A; Iwata S; Sakagami J; Ukai Y; Ono M; Kanbe D; Muramatsu S; Kobayashi K; Iwatsubo T; Yoshimoto M Neurobiol Aging; 2008 Apr; 29(4):574-85. PubMed ID: 17174013 [TBL] [Abstract][Full Text] [Related]